CRGO (CRGO) insider Zvi Schreiber reports multiple share sales

Rhea-AI Filing Summary

ZVI SCHREIBER filed a Form 144 reporting dispositions of Ordinary shares. The filing lists multiple sales executed between 03/11/2026 and 05/20/2026, including blocks of 5,000, 10,000, 15,000, and 20,000 shares on specific dates with the corresponding gross proceeds shown alongside each trade.

Insights

Securities Compliance Specialist

Form 144 lists multiple completed sales by a reporting holder between March and May 2026.

The filing names ZVI SCHREIBER as the reporting party and enumerates specific sales dates and share quantities from 03/11/2026 through 05/20/2026. Each row pairs a share count with a dollar amount representing gross proceeds for that trade.

Cash‑flow treatment and whether sales were pursuant to a trading plan are not stated in the excerpt; subsequent public filings or broker confirmations would show any additional disposition details.

Key Figures

Sale on 05/20/2026: 15,000 shares Proceeds on 05/20/2026: $30,750.00 Sale on 05/11/2026: 20,000 shares +3 more

6 metrics

Sale on 05/20/2026 15,000 shares sale executed 05/20/2026

Proceeds on 05/20/2026 $30,750.00 gross proceeds for 15,000 shares on 05/20/2026

Sale on 05/11/2026 20,000 shares sale executed 05/11/2026

Proceeds on 05/11/2026 $41,017.45 gross proceeds for 20,000 shares on 05/11/2026

Earliest listed sale 5,000 shares sale executed 03/11/2026 for $6,300.00

Restricted award date 01/01/2012 Restricted stock vesting under a registered plan (20,000 shares listed)

Key Terms

Form 144, Restricted stock vesting, Gross proceeds

3 terms

Form 144 regulatory

"filed a Form 144 reporting dispositions of Ordinary shares"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted stock vesting financial

"Restricted stock vesting under a registered plan"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Gross proceeds financial

"each trade pairs a share count with a dollar amount representing gross proceeds"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	39000.00	51376890	05/26/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/01/2012	Restricted stock vesting under a registered plan	Issuer			20000	01/01/2012	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	05/20/2026	15000	30750.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	05/11/2026	20000	41017.45
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	05/06/2026	20000	41000.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	05/04/2026	20000	41000.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/28/2026	15000	30750.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/17/2026	10000	21300.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/15/2026	10000	18500.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/13/2026	10000	16200.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/08/2026	10000	16900.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/01/2026	5000	8200.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/30/2026	5000	8150.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/24/2026	10000	15850.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/17/2026	10000	16508.50
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/16/2026	10000	15214.04
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/11/2026	5000	6300.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did ZVI SCHREIBER report in the Form 144 for CRGO?

The Form 144 reports multiple dispositions of Ordinary shares by ZVI SCHREIBER, listing executed trades between 03/11/2026 and 05/20/2026. Each trade shows the number of shares and gross proceeds alongside the trade date.

How many shares were sold on 05/20/2026 according to the filing?

The filing shows a sale of 15,000 Ordinary shares on 05/20/2026 with gross proceeds listed as $30,750.00 in the presented excerpt.

Are there examples of earlier sales in the Form 144 excerpt?

Yes; the excerpt includes sales such as 5,000 shares on 03/11/2026 for $6,300.00 and multiple 10,000–20,000 share transactions in March and April with their respective proceeds.

Does the excerpt state whether proceeds go to the issuer or selling holder?

The excerpt pairs each trade with gross proceeds amounts, but it does not state the recipient of proceeds; the filing structure indicates these are dispositions by the reporting holder rather than issuer receipts.

Is the filing connected to restricted stock vesting or compensation?

The excerpt includes an entry labeled Restricted stock vesting under a registered plan with a grant date of 01/01/2012, indicating some securities originated from compensation-related awards.